European Archives - Page 247 of 1003 - European Medical Journal

Sudden Cardiac Arrest in Patients with Type 2 Diabetes

New research has identified a range of characteristics associated with an increased risk of sudden cardiac arrest in patients with Type 2 diabetes. However, it remains difficult to predict, especially in those without a history of cardiovascular disease.

Navigating the Complexities of Metastatic Colorectal Cancer: From Genetic Mutations to Targeted Therapies

Two experts in medical oncology explore the latest developments in metastatic colorectal cancer in this episode of the EMJ podcast.

Does a History of Cancer Increase Hearing Loss Risk?

According to research, the risk of hearing loss is greater in individuals who are survivors of cancer. This is due to age and the effects of previous chemotherapy and radiotherapy. Read more.

Lung Cancer: Disparities in Incidence Rates

Incidence rates for lung cancer in US females aged 35-54 were higher than in males and older females, according to research by Ahmedin Jemal, American Cancer Society, Atlanta, Georgia, USA, and colleagues.

Healthcare Inequalities and the Exposome

Michelle Kelly-Irving joins Jonathan to speak about social, economic, and gender inequalities in healthcare, as well as the exposome.

Atypical Hepatitis B-Associated Vasculitis

One of the many extra-hepatic manifestations of hepatitis B virus (HBV) infections is vasculitis. While the classic HBV-associated…

Fibromyalgia: Insights and Perspectives from the Patient and Practitioner

This podcast series explores fibromyalgia from the patient and practitioner perspectives, featuring personal insights and the use of non-pharmacological approaches.

Positive Impact of Prenatal Iron Supplements

Iron supplementation during pregnancy has been shown to successfully reduce maternal anaemia. However, access is not universal. Read more about he direct dispensation of iron supplements during follow-ups

Non-opioid pain medication wins FDA approval

FDA approved a new non-opioid medication for patients with post-operative pain who are being treated in hospital. Read more now.

Investigating the reality of rare disease research

Discover the reality behind the rare disease research with Dr Ian Winburn, Vice President, Global Lead for Rare Hematology, Pfizer